1Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81:8B- 12B.
2Temelkova- Kurktschiev T, Koehler C, Henkel E, et al.Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level, Diabetes Care 2000; 23 : 1830 - 1834.
3Carroll MF, Izard A, Riboni K, et al. Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia:implications for diabetes therapy. Diabete care 2002; 25:1247 -1248.
4Ceriello A, Taboga C, tonutti L, et al, Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short - and long - term simvastatin treatment, Circulation 2002 ; 106:1211 - 1218.
5Grundy S, Garber A, Goldberg R, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: Lifestyle and medical management of risk factors, Circulation 2002 ; 105 : e153 - e158.
6Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med 2002;346:393 - 403.
7Haffner S, Greenberg A, Weston W, et al. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 2002; 106 : 679 - 684.
